GlassScriptPhysician profile
Brad A Culotta
NPI 1467655456
$81,547.86
in general payments reported to CMS, 2019-2025
30 companies · $2,146 in 2025
The $2,146 reported for 2025 was more than what 82% of Pediatric Orthopaedic Surgery providers received nationally (typical 2025 total: $271).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,474 · 2020: $1,564 · 2021: $15K · 2022: $17K · 2023: $15K · 2024: $27K · 2025: $2,146.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $33K · Travel and Lodging: $7,540 · Food and Beverage: $3,004 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $33,350.00 |
| Travel and Lodging | $7,539.55 |
| Food and Beverage | $3,003.83 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $175.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $69,544.60 | 2019-2025 | Airo, Everest Spinal System, N/A |
| Orthopediatrics Corp. | $3,977.55 | 2021-2025 | |
| Innovasis INC | $3,265.40 | 2019 | |
| Alphatec Spine, INC | $2,021.95 | 2023-2025 | Other - Miscellaneous, Invictus Mis, Invictus Open |
| Alon Medical Technology | $613.19 | 2023-2025 | |
| Globus Medical, INC. | $280.93 | 2023-2025 | Excelsius Gps, Reline, Bendini |
| Arthrex, INC. | $219.95 | 2025 | |
| Medtronic, INC. | $217.54 | 2024-2025 | Unid_pass |
| Boston Scientific Corporation | $212.12 | 2021-2025 | General - Pain Management |
| Biomarin Pharmaceutical INC. | $172.53 | 2020-2024 | Voxzogo 1.2mg |
| Next Science LLC | $124.69 | 2023 | Surgx, Xperience, Blastx |
| Smith+Nephew, INC. | $119.56 | 2019-2025 | Allevyn Heel 10.5cm X 13.5cm Ctn 5, Pico |
| Wishbone Medical INC. | $110.55 | 2021 | |
| Zimvie INC. | $72.22 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $70.51 | 2021-2023 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biocomposites INC | $61.28 | 2025 | Stimulan |
| Pacira Pharmaceuticals Incorporated | $58.95 | 2021-2025 | Exparel |
| Depuy Synthes Sales INC. | $57.20 | 2022-2023 | Na |
| Vericel Corporation | $42.02 | 2022 | |
| Sanara Medtech INC. | $41.92 | 2023-2025 | Celleraterx, Celleraterx |
| Medical Device Business Services, INC. | $40.11 | 2025 | Stratafix |
| Orthofix Medical, INC. | $38.34 | 2019-2020 | |
| Sarepta Therapeutics, INC. | $30.55 | 2023 | Elevidys |
| Kyowa Kirin, INC. | $29.42 | 2025 | |
| Solventum Corporation | $27.78 | 2024 | V.A.C.Ulta, V.A.C. Veraflo, Prevena |
| Convatec INC. | $26.27 | 2025 | |
| Nuvasive, INC. | $26.26 | 2019 | |
| Medtronic USA, INC. | $18.78 | 2019 | |
| Alexion Pharmaceuticals, INC. | $14.83 | 2022 | |
| Allergan, INC. | $10.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brad Culotta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.